losing too much weight on tirzepatide ✨ patient — 6 months later🔥 40 pounds down and feeling stronger than ever 🙌 Thanks to healthy habits, consistency, and exercise, this patient didn't just lose — they were Adults with obesity using tirzepatide

FDA Approval and Safety Profile for Non-Diabetic Weight Loss The FDA approved tirzepatide under the brand name Zepbound specifically for chronic weight management in adults without diabetes in November 2023

The US Food & Drug Administration (FDA) first approved Mounjaro in 2022 as a treatment for type 2 diabetes

It stimulates the pituitary gland to release growth hormone by activating ghrelin receptors

Doses below 500 mg/day showed inconsistent results

Appetite or gastrointestinal changes may occur early, but a meaningful weight trend is generally evaluated over months

This will equate to about 30 million Americans and has already contributed to a labor shortage in the U.S